Rigaku Corp, Supplier for £1M Enhancement to X-ray Facility
News Apr 11, 2014
Rigaku Corporation is pleased to announce that it will be supplying X-ray equipment for a new state-of-the-art laboratory opening at the University of St Andrews today.
In attendance at the ribbon-cutting ceremony will be Dr Joseph Ferrara, Vice President, X-ray Research Laboratory, Rigaku Corporation. The Laboratory for Chemical Crystallography will be officially opened and directed by Alex Slawin, Professor of Chemical Crystallography at the university.
The newly updated facility, combining expertise with Rigaku, the leading Japanese manufacturer of X-ray related technologies, will support a wide range of cutting-edge research, including new green chemistry, drug discovery and materials applications, as well as the teaching of crystallography.
It will also be home to some of the most sophisticated X-ray technology in the world, supplied by Rigaku Corporation. The £1M enhancement (funded by EPSRC) includes new advanced detector and X-ray technology, featuring the most advanced X-ray generators, optics and Dectris detectors for the home lab. Rigaku is pleased to continue to be a partner in the development of the facility and looks forward to a long term relationship with St. Andrews.
Building Molecular Wires, One Atom at a TimeNews
Electronic devices are getting smaller and smaller. Early computers filled entire rooms. Today you can hold one in the palm of your hand. Now the field of molecular electronics is taking miniaturization to the next level. Researchers are creating electronic components so tiny they can’t be seen with the naked eye.READ MORE
Longevity Protein Reveals its SecretsNews
In a recent study, researchers revealed the three-dimensional structure of a proteins linked to longevity and metabolism, beta-Klotho, illuminating its intricate mechanism and therapeutic potential. The study findings could have implications for therapies developed to treat a wide range of medical conditions, including diabetes, obesity, and certain cancers.READ MORE
Multidisciplinary Study Suggests New Strategy for Drug DiscoveryNews
A joint industry/academia study of a cancer target protein reveals unusual relation between binding site flexibility and drug-target lifetime. The results, , suggest a new strategy for drug discovery.READ MORE